Urogen Pharma (URGN) shares soared 9.7% in the last trading session to close at 19.20.Themovewasbackedbysolidvolumewithfarmoreshareschanginghandsthaninanormalsession.Thiscomparestothestock′s32.50.88 per share in its upcoming report, which represents a year-over-year change of +14.6%. Revenues are expected to be $23.69 million, up 12% from the year-ago quarter. For Urogen Pharma, the consensus EPS es ...